For the September 14, 2016 meeting of the FDA's Pediatric Advisory Committee
Persons with disabilities having problems accessing any of the PDF files below may call 240-402-3838 for assistance.
- Bloxiverz Safety and Drug Utilization Review
- Bloxiverz Labeling, 9/2015
- Presentation: Pediatric Focused Safety Review for Bloxiverz
- Bloxiverz Clinical Review
- Bloxiverz Clinical Pharmacology Review